Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss

NCT03725306 is registered in ClinicalTrials.gov with LiNA Medical as lead sponsor.

NCT NCT03725306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03725306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss
Lead sponsor
LiNA Medical
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2019
Completion date
December 1, 2022
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding, menorrhagia